Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Short-Term Debt issuances (2023 - 2025)

Cannabis Bioscience International Holdings' Short-Term Debt issuances history spans 3 years, with the latest figure at $24761.0 for Q2 2025.

  • For Q2 2025, Short-Term Debt issuances rose 234.61% year-over-year to $24761.0; the TTM value through May 2025 reached $139.0, up 200.0%, while the annual FY2025 figure was $139.0, 200.0% up from the prior year.
  • Short-Term Debt issuances for Q2 2025 was $24761.0 at Cannabis Bioscience International Holdings, up from -$102059.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $116075.0 in Q4 2024 and bottomed at -$102059.0 in Q1 2025.
  • The 3-year median for Short-Term Debt issuances is $4751.5 (2023), against an average of $950.3.
  • The largest YoY upside for Short-Term Debt issuances was 3305.61% in 2024 against a maximum downside of 864.65% in 2024.
  • A 3-year view of Short-Term Debt issuances shows it stood at -$3621.0 in 2023, then skyrocketed by 3305.61% to $116075.0 in 2024, then plummeted by 78.67% to $24761.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Short-Term Debt issuances are $24761.0 (Q2 2025), -$102059.0 (Q1 2025), and $116075.0 (Q4 2024).